Cargando…

Early Surfactant Therapy for Respiratory Distress Syndrome in Very Preterm Infants

Background: It is currently considered that early initiation of nasal continuous positive airway pressure, using a less invasive exogenous surfactant administration and avoiding mechanical ventilation as much as possible to minimize lung damage, may reduce mortality and/or the risk of morbidities in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cucerea, Manuela, Moscalu, Mihaela, Moldovan, Elena, Santa, Reka, Gall, Zsuzsanna, Suciu, Laura Mihaela, Simon, Marta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914192/ https://www.ncbi.nlm.nih.gov/pubmed/36767013 http://dx.doi.org/10.3390/healthcare11030439

Ejemplares similares

Aerosolized Surfactant for Preterm Infants with Respiratory Distress Syndrome
por: Brasher, Mandy, et al.
Publicado: (2021)

Trial of aerosolised surfactant for preterm infants with respiratory distress syndrome
por: Jardine, Luke, et al.
Publicado: (2022)

Surfactant preparations for preterm infants with respiratory distress syndrome: past, present, and future
por: Jeon, Ga Won
Publicado: (2019)

Practical considerations when administering surfactants to preterm infants with respiratory distress syndrome
por: Jo, Heui Seung
Publicado: (2019)

Profound Effect of Pulmonary Surfactant on the Treatment of Preterm Infants with Respiratory Distress Syndrome
por: Liu, Lin, et al.
Publicado: (2022)

Alternative Methods of Surfactant Administration in Preterm Infants with Respiratory Distress Syndrome: State of the Art
por: Erdeve, Ömer, et al.
Publicado: (2021)

Comparative evaluation of echocardiography indices during the transition to extrauterine life between small and appropriate for gestational age infants
por: Suciu, Laura Mihaela, et al.
Publicado: (2023)

Effects of bovine lipid extract surfactant administration in preterm infants treated for respiratory distress syndrome
por: Stockley, Elizabeth, et al.
Publicado: (2018)

Surfactant replacement therapy for respiratory distress syndrome in preterm infants: United Kingdom national consensus
por: Banerjee, Sujoy, et al.
Publicado: (2019)

Surfactant therapy in preterm infants with respiratory distress syndrome and in near-term or term newborns with acute RDS
por: Ramanathan, R
Publicado: (2006)

Effect of surfactant dose on outcomes in preterm infants with respiratory distress syndrome: the OPTI-SURF study protocol
por: Goss, Kevin Colin William, et al.
Publicado: (2020)

Optimally Controlled Diabetes and Its Influence on Neonatal Outcomes at a Level II Center: A Study on Infants Born to Diabetic Mothers
por: Muntean, Mihai, et al.
Publicado: (2023)

Efficacy of Surfactant-TA, Calfactant and Poractant Alfa for Preterm Infants with Respiratory Distress Syndrome: A Retrospective Study
por: Jeon, Ga Won, et al.
Publicado: (2015)

Single Nucleotide Polymorphisms Interactions of the Surfactant Protein Genes Associated With Respiratory Distress Syndrome Susceptibility in Preterm Infants
por: Amatya, Shaili, et al.
Publicado: (2021)

The Influence of the Technique of Surfactant Administration (LISA vs INSURE) on the Outcomes of Respiratory Distress Syndrome Treatment in Preterm Infants
por: Kaniewska, Urszula, et al.
Publicado: (2019)

Comparative efficacy of pulmonary surfactant in respiratory distress syndrome in preterm infants: a Bayesian network meta-analysis
por: Qiu, Caihong, et al.
Publicado: (2020)

Outcomes at 7 Years of Age of Former Very Preterm Neonates with Repeated Surfactant Treatment for Prolonged Respiratory Distress in the Neonatal Period
por: Hascoet, Jean-Michel, et al.
Publicado: (2023)

Early Prophylactic versus Late Selective Use of Surfactant for Respiratory Distress Syndrome in Very Preterm Infants: A Collaborative Study of 53 Multi-Center Trials in Korea
por: Kim, Sung Mi, et al.
Publicado: (2014)

Comparison of minimally invasive surfactant therapy with intubation surfactant administration and extubation for treating preterm infants with respiratory distress syndrome: a randomized clinical trial
por: Sabzehei, Mohammad Kazem, et al.
Publicado: (2021)

Early Immunomodulatory Effects of Different Natural Surfactant Preparations in Preterms With Respiratory Distress
por: Yalaz, Mehmet, et al.
Publicado: (2022)

Early administration of surfactant via a thin intratracheal catheter in preterm infants with respiratory distress syndrome: Feasibility and outcome
por: Mohammadizadeh, Majid, et al.
Publicado: (2015)

Corrigendum: Single nucleotide polymorphisms interactions of the surfactant protein genes associated with respiratory distress syndrome susceptibility in preterm infants
por: Amatya, Shaili, et al.
Publicado: (2022)

Changes Overtime in Perinatal Management and Outcomes of Extremely Preterm Infants in One Tertiary Care Romanian Center
por: Ungureanu, Diana, et al.
Publicado: (2022)

Early Respiratory Management of Respiratory Distress Syndrome in Very Preterm Infants and Bronchopulmonary Dysplasia: A Case-Control Study
por: te Pas, Arjan B., et al.
Publicado: (2007)

FiO(2) Before Surfactant, but Not Time to Surfactant, Affects Outcomes in Infants With Respiratory Distress Syndrome
por: Kruczek, Piotr, et al.
Publicado: (2021)

Analysis of the cost-effectiveness of surfactant treatment (Curosurf®) in respiratory distress syndrome therapy in preterm infants: early treatment compared to late treatment
por: Dani, Carlo, et al.
Publicado: (2014)

A multicentre neonatal interventional randomised controlled trial of nebulized surfactant for preterm infants with respiratory distress: Neo-INSPIRe trial protocol
por: Lategan, Ilse, et al.
Publicado: (2023)

Surfactants in Acute Respiratory Distress Syndrome in Infants and Children: Past, Present and Future
por: Amigoni, Angela, et al.
Publicado: (2017)

RETREATMENT WITH SURFACTANT IN VERY LOW BIRTH WEIGHT PRETERM INFANTS: RISK PREDICTORS AND THEIR INFLUENCE ON NEONATAL OUTCOMES
por: Ferri, Walusa Assad Gonçalves, et al.
Publicado: (2020)

Assessment of Comfort during Less Invasive Surfactant Administration in Very Preterm Infants: A Multicenter Study
por: Pichler, Karin, et al.
Publicado: (2023)

The Role of Surfactant in Respiratory Distress Syndrome
por: Ma, Christopher Cheng-Hwa, et al.
Publicado: (2012)

Assessment of hemodynamic changes in preterm infants with respiratory distress syndrome
por: Özdemir, Senem Alkan, et al.
Publicado: (2017)

Bronchoscopic interventions with surfactant and recombinant human deoxyribonuclease for acute respiratory distress syndrome–type respiratory syncytial virus–pneumonia in moderately preterm infants: Case series
por: Krause, Martin F, et al.
Publicado: (2014)

Surfactant treatment before first breath for respiratory distress syndrome in preterm lambs: comparison of a peptide-containing synthetic lung surfactant with porcine-derived surfactant
por: van Zyl, Johann M, et al.
Publicado: (2013)

Effects of less invasive surfactant administration versus intubation-surfactant-extubation on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: a single-center, retrospective study from China
por: Xu, Chun-cai, et al.
Publicado: (2022)

Outcome of Very Premature Newborn Receiving an Early Second Dose of Surfactant for Persistent Respiratory Distress Syndrome
por: Greiner, Eva, et al.
Publicado: (2021)

A pilot study of less invasive surfactant administration in very preterm infants in a Chinese tertiary center
por: Bao, Yingying, et al.
Publicado: (2015)

The Administration of 100% Oxygen and Respiratory Drive in Very Preterm Infants at Birth
por: van Vonderen, Jeroen J., et al.
Publicado: (2013)

Surfactant proteins gene variants in premature newborn infants with severe respiratory distress syndrome
por: Somaschini, Marco, et al.
Publicado: (2017)

Transient intubation for surfactant administration in the treatment of respiratory distress syndrome in extremely premature infants
por: Koh, Ji Won, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_te36mkrqsqbip8hma447ij5f0p